Kesehatan
Who benefits from the panic around the new type of Corona virus? The situation is under control, and there is now cause for worrying. In the early 2000s, around 100 billion USD was spent to “contain the spread” of the SARS-Co virus. In 18 years, around 700 people have died from it – just as many who dies from a usual influenza. In this case, the big pharmaceutical companies could profit largely. Why this panic? The answer is the classical: “who benefits from it?”
Benarkah?
Salahmenurut EUvsDisinfo
EUvsDisinfo mengecek klaim ini pada 27 Januari 2020.
“disinformation”
Seputar klaim ini
- Pertama kali terlihat
- 27 Januari 2020, tsargrad.tv, menurut EUvsDisinfo (EEAS East StratCom Task Force)
Di mana klaim ini muncul
- Terlihat di tsargrad.tv, menurut EUvsDisinfo (EEAS East StratCom Task Force), 27 Januari 2020
Terkait
Selengkapnya di Kesehatan
Lihat semua 16.580 cek fakta- Menyesatkanmenurut FactCheck.org20 November 2026The Moderna mRNA flu vaccine “didn’t work” and came with “massive side effects.”KesehatanAmerika SerikatInggris
- Sudah dicekoleh Factcrescendo Sri Lanka20 November 2026That the price of a bottle of arrack (750 ml extra special arrack) has been reduced by 530 rupees, and that alcohol prices went down with the 2027 budgetTerjemahan mesin ke bahasa Inggris dari Sinhala. Aslinya: ගල් අරක්කු (මිලි ලීටර් 750 අති විශේෂ අරක්කු) බෝතලයක මිල රුපියල් 530කින් අඩු කර ඇති බවත්, 2027 අයවැයෙන් මත්පැන් මිල පහළ ගිය බවත්Ekonomi dan uangSri Lanka
- Sudah dicekoleh فکتنامه19 November 2026Can iron deficiency and anemia be diagnosed from a person's face?Terjemahan mesin ke bahasa Inggris dari Persia. Aslinya: آیا میتوان کمبود آهن و کمخونی را از روی چهره تشخیص داد؟Kesehatan
Ada yang salah di sini? Laporkan lewat emailinfo@factiz.org
Kesimpulan adalah milik redaksi: laporkan kesalahan di dalamnya kepada mereka, lewat artikel mereka di atas. Laporkan kesalahan pada hal yang ditambahkan Factiz, seperti terjemahan, tema, atau nama, kepada kami.
Data dari: EUvsDisinfo, European External Action Service. Lisensi: EEAS legal notice: reuse is authorised, provided the source is acknowledged; snapshot: Mendeley Data yhdtkszvgp v3, CC BY 4.0.
Sumbernya adalah kesimpulannya.